SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein binds to the cell receptor ACE2 allowing viral entry and infection. It is a 223 amino acid glycoprotein representing residues 319-541 of the spike protein S1 sequence. RBD from Molecular Innovations is useful for capturing SARS-CoV-2 specific antibodies from human plasma and serum in COVID-19 serological assays. Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 6X-Histidine tag at C terminus for purification.
Produced under license from the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Purity：>95% by SDS-PAGE analysis
Source：Human Embryonic Kidney cells
Molecular Weight：25,900
Extinction Coefficient：1.231
Storage：-70 C
Shipping Conditions：Dry ice
Expiration：3 years from delivery
Form ：Frozen liquid
Buffer：PBS
Sample Size：0.05 mg
Sample Concentration ：0.25 mg/ml
Sample Volume ：0.2 ml
Gene Name：S1
Gene ID：43740568
UniProt ID：P0DTC2
400-888-0207
